BioGeneration Ventures
Overview
BioGeneration Ventures is a venture capital firm specializing in seed and early-stage investments for innovative European life sciences companies, including biotech, medtech, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Evinced | Dec 2024 | Series C | Co-investor |
| EverestLabs | Sep 2022 | Series A | Co-investor |
| Upsun | Jun 2022 | Series D | Co-investor |
| Avidicure | Apr 2025 | Seed | Co-investor |
| Greenly | Mar 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Edward van Wezel
Founder and Managing Partner
Daniela Couto
General Partner
Keno Gutierrez
General Partner
Alexander Vos
Venture Partner
Andrew Lightfoot
Venture Partner
Arnoud Dijkstra
Venture Partner
Dominique Baeten
Venture Partner
Elena Ritsou
Venture Partner
Markus Kalousek
Venture Partner
Diede Brunen
Principal
Rianne Ellenbroek
Principal
Margien Boels
Investment Manager FIRST Fund
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioGeneration Ventures based?
BioGeneration Ventures is headquartered in Naarden, Netherlands.
When was BioGeneration Ventures founded?
BioGeneration Ventures was founded in 2006.
How many portfolio companies does BioGeneration Ventures have?
BioGeneration Ventures has 34 portfolio companies in Caplight's dataset.
What are some companies in BioGeneration Ventures's portfolio?
Portfolio companies visible on Caplight include Evinced, EverestLabs, Upsun, Avidicure, Greenly.
What was BioGeneration Ventures's most recent investment shown here?
BioGeneration Ventures's most recent investment in this portfolio sample was in Avidicure in 2025.
What sectors does BioGeneration Ventures focus on?
BioGeneration Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Energy & Sustainability, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Consumer & Commerce, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does BioGeneration Ventures focus on?
BioGeneration Ventures typically invests at the MultiStage stage.
What is BioGeneration Ventures's AUM?
BioGeneration Ventures's assets under management are estimated between $250.0M and $500.0M.